Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.57M Buy
7,291
+566
+8% +$202K 0.39% 47
2025
Q4
$2.2M Buy
6,725
+35
+0.5% +$11.1K 0.33% 52
2025
Q3
$1.89M Buy
6,690
+159
+2% +$46.1K 0.3% 63
2025
Q2
$1.82M Buy
6,531
+241
+4% +$68.3K 0.31% 59
2025
Q1
$1.96M Buy
6,290
+143
+2% +$42.2K 0.38% 48
2024
Q4
$1.6M Buy
6,147
+64
+1% +$19K 0.31% 56
2024
Q3
$1.96M Buy
6,083
+159
+3% +$52K 0.38% 49
2024
Q2
$1.85M Buy
5,924
+282
+5% +$82.8K 0.4% 50
2024
Q1
$1.6M Buy
5,642
+99
+2% +$29K 0.36% 56
2023
Q4
$1.6M Buy
5,543
+109
+2% +$29.7K 0.42% 51
2023
Q3
$1.46M Sell
5,434
-288
-5% -$71.9K 0.46% 45
2023
Q2
$1.27M Sell
5,722
-248
-4% -$57.5K 0.4% 51
2023
Q1
$1.57M Hold
5,970
0.56% 42
2022
Q4
$1.57M Buy
5,970
+91
+2% +$24.4K 0.56% 42
2022
Q3
$1.43M Buy
5,879
+106
+2% +$25.7K 0.58% 45
2022
Q2
$1.41M Buy
5,773
+124
+2% +$30.4K 0.67% 39
2022
Q1
$1.37M Buy
5,649
+61
+1% +$14K 0.47% 52
2021
Q4
$1.26M Buy
+5,588
New +$1.18M 0.44% 59

Other funds holding AMGN

Regatta Capital Group's AMGN Position: Q1 2026 in Review

Regatta Capital Group increased its Amgen (AMGN) stake by 8.4% in Q1 2026, buying an estimated $202K and bringing the position to 7,291 shares worth $2.57M. The position accounts for 0.39% of the portfolio, ranked #47.

Regatta Capital Group first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Regatta Capital Group held 7,291 shares of Amgen worth $2.57M as of Q1 2026.
  • Regatta Capital Group bought 566 Amgen shares in Q1 2026, an estimated $202K.
  • Amgen made up 0.39% of Regatta Capital Group's portfolio in Q1 2026, its #47 holding.
  • Regatta Capital Group first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Regatta Capital Group's 13F filing for Q1 2026, filed 15 Apr 2026.